Vanderbilt researchers have developed a new nanoparticle that can more effectively get drugs inside of cells to boost the immune system and fight diseases like cancer.

Vanderbilt researchers are working to better design immune therapies that attack tumors without also attacking healthy normal tissue in patients.

Kimryn Rathmell MD PhD MMHC the Hugh Jackson Professor of Medicine and chair of the Department of Medicine at Vanderbilt University Medical Center will be appointed Director of the National Cancer Institute.

Vanderbilts James E. Crowe Jr MD and Neil Osheroff PhD are among 12 individuals honored by the Association of American Medical Colleges during its 2023 Awards Recognition Event.

A multidisciplinary team of investigators has received a 2023 Endeavor Award from The Mark Foundation for Cancer Research to support four closely linked projects exploring the fundamental mechanisms that drive the obesity-cancer connection

Chemical and biomedical engineer and cancer researcher Marjan Rafat has received the Young Innovator Award from the Cellular and Molecular Bioengineering division of the Biomedical Engineering Society. The CMBE Young Innovator Award is a distinguished honor for young faculty in the biomolecular engineering field.

Vanderbilts Center for Technology Transfer and Commercialization named Richard Caprioli C. David Weaver Susan Eagle and Franz Baudenbacher 2023 Master Innovators. The yearly recognition program acknowledges Vanderbilts top innovators and entrepreneurs for their contributions to the creation development and commercialization of intellectual property.